Global Drug Treatment Market: Overview
The threat of drugs has been eating away at our society for decades now. On the one hand, the authorities and the police are trying to reduce the problem with an iron fist, on the other hand, the health institutes and the pharmaceutical companies are doing everything possible to cure the addiction.
This gave rise to the addiction treatment market which has gradually grown over the years. Treatments can take place in different settings and can involve both medications and behavioral therapies. Depending on the severity of the situation, the duration of treatment may vary. Since drug addiction is primarily a chronic disorder characterized by occasional relapses, one treatment is usually not enough. It is generally long requiring multiple interventions and punctual follow-up.
Some of the drugs commonly used in addiction treatment are methadone, buprenorphine, and naltrexone, which are given to people who are addicted to opioids. Nicotine preparations in the form of patches, lozenges, gum and nasal spray as well as the drugs varenicline and bupropion are intended to treat tobacco addiction. Additionally, behavioral therapies are used to help addicts cope with drug cravings and thwart a relapse.
The United States is one of the main addiction treatment markets due to a large proportion of drug addicts. However, the market could suffer a major setback if the new government manages to pass the bill repealing the Affordable Care Act which provides substantial coverage for drug treatment. It is estimated that this is likely to affect nearly 1.3 million people with mental health and substance use disorders.
Global Drug Treatment Market: Overview
The drug epidemic has serious economic repercussions in the United States every year. This includes costs incurred in fighting crime, lost work productivity and rehabilitation programs. The National Institute on Drug Abuse (NIDA) defines substance abuse as a complex condition marked by extreme cravings for drugs and other addictive substances as well as excessive seeking of these substances.
The approach of the drug treatment program varies from person to person. The goal of the treatment program is to help patients maintain abstinence from addictive substances and achieve effective functioning in personal and professional life. Recommended treatment programs can be residential or outpatient depending on the severity of the addiction, the type of substance, and the behavior of the patient. Therefore, drug treatment programs include counseling (psychotherapy), outpatient and inpatient programs, and self-help groups.
Outpatient behavioral treatments include multidimensional family therapies, cognitive behavioral therapies, and motivational interviewing; while residential treatment programs include a stay in a rehabilitation center for a period of about six to twelve months.
The report is a valuable tool for understanding developments in the global drug addiction treatment market during the forecast period. The report presents a comprehensive analysis of market drivers, market challenges and opportunities that will impact the progress of the global drug addiction treatment market for the period 2017-2025. In this report, market segments and growth indicators are analyzed for historical years based on which projections are made for the forecast period. The report also presents the growth roadmap of key companies in the market that will lead to changes in the competitive hierarchy.
Global Drug Treatment Market: Market Segmentation
The global addiction treatment market is segmented on the basis of treatment approach and geography. By therapeutic approach, drugs and therapy are the components of this market. Based on geography, North America, Europe, Asia-Pacific, and Rest of the World are components of this market.
Global Drug Treatment Market: Regulatory Approval of Drugs
The United States Food and Drug Administration (FDA) has approved naltrexone, acamprosate, and disulfiram for the treatment of alcohol dependence. Topiramate is a drug that is showing encouraging results in clinical trials for the treatment of alcohol dependence. Some of the formulations to treat nicotine addiction include gummies, lozenges, patches, and sprays. Additionally, the FDA has approved two prescription drugs for the treatment of nicotine addiction, namely bupropion and varenicline.
Global Drug Treatment Market: Drivers and Restraints
The increased use of addictive substances such as alcohol, tobacco, and drugs, along with the increase in marketing initiatives aimed at raising awareness about the harmful effects of drug addiction, are driving the global drug addiction treatment market. On the other hand, factors such as reluctance to opt for rehabilitation programs and lack of mental and physical stability of patients during treatment programs are hampering the growth of this market.
Leading companies in the global addiction treatment market
The report depicts the competitive scenario of the global drug addiction treatment market with a detailed business profile of major companies operating in the market. GlaxoSmithKline plc, Reckitt Benckiser plc, Pfizer Inc. and Orasure Technologies are some of the major companies operating in this market.
About VMR Research
TMR Research is a leading provider of custom market research and advisory services to business entities seeking to succeed in today’s supercharged economic climate. Backed by a team of experienced, dedicated and dynamic analysts, we redefine the way our clients do business by providing them with authoritative and reliable research studies, in line with the latest methodologies and market trends.
3739 Balboa Street #1097,
San Francisco, California 94121